![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 26, 2012 7:34:07 AM
The exposure will be HUGE with this weekend’s conference for $EKNL and their FDA approved FREMS technologies. EKNL will also be increasing their exposure with 2 additional shows this year – a big step forward for the company and shareholder’s value.
EKO International Corp – NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario PR Newswire(Tue 10:04AM EDT)
EKNL continues to impress, and with the PR campaign gearing up, we anticipate a series of big updates and significant sales contract to follow as early as next week.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM